Placebo Effects in a Multiple Sclerosis Spasticity Enriched Clinical Trial with the Oromucosal Cannabinoid Spray (THC/CBD): Dimension and Possible Causes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Placebo Effects in a Multiple Sclerosis Spasticity Enriched Clinical Trial with the Oromucosal Cannabinoid Spray (THC/CBD): Dimension and Possible Causes
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 21, Issue 3, Pages 215-221
Publisher
Wiley
Online
2014-12-09
DOI
10.1111/cns.12358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comparison between Enriched and Nonenriched Enrollment Randomized Withdrawal Trials of Opioids for Chronic Noncancer Pain
- (2016) Andrea D Furlan et al. Pain Research & Management
- Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals
- (2014) S. Vlachou et al. CURRENT PHARMACEUTICAL DESIGN
- Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
- (2014) Peter Flachenecker et al. EUROPEAN NEUROLOGY
- Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis
- (2014) Silvia Rossi et al. PLoS One
- Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
- (2014) John M. McPartland et al. PLoS One
- Challenges in design and interpretation of chronic pain trials
- (2013) R.A. Moore et al. BRITISH JOURNAL OF ANAESTHESIA
- FAAH selectively influences placebo effects
- (2013) M Peciña et al. MOLECULAR PSYCHIATRY
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes
- (2012) Marina Mitjans et al. JOURNAL OF PSYCHOPHARMACOLOGY
- An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain
- (2012) Cory Toth et al. PAIN
- Effect of spinal cord injury and of intrathecal baclofen on brainstem reflexes
- (2011) Hatice Kumru et al. CLINICAL NEUROPHYSIOLOGY
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives
- (2011) Eva M Marco et al. JOURNAL OF PSYCHOPHARMACOLOGY
- An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia
- (2011) LYNNE PAUER et al. JOURNAL OF RHEUMATOLOGY
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- (2011) W Notcutt et al. Multiple Sclerosis Journal
- Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors
- (2011) Fabrizio Benedetti et al. NATURE MEDICINE
- Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
- (2011) Nimish Sidhpura et al. NEUROPHARMACOLOGY
- Cannabinoids and emotionality: a neuroanatomical perspective
- (2011) R.J. McLaughlin et al. NEUROSCIENCE
- Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo
- (2011) Espen Bjørkedal et al. PSYCHOPHARMACOLOGY
- Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
- (2010) Derick T Wade et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans
- (2009) Giacomo Koch et al. Brain Stimulation
- Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis
- (2009) F. Mori et al. EUROPEAN JOURNAL OF NEUROLOGY
- Does the presence of a pharmacological substance alter the placebo effect?-results of two experimental studies using the placebo-caffeine paradigm
- (2009) Harald Walach et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Fluoxetine Treatment Modulates Cannabinoid Type 1 Receptor-Mediated Inhibition of Adenylyl Cyclase in the Rat Prefrontal Cortex through 5-Hydroxytryptamine1A Receptor-Dependent Mechanisms
- (2009) S. Mato et al. MOLECULAR PHARMACOLOGY
- Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
- (2008) John T. Farrar et al. CLINICAL THERAPEUTICS
- Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
- (2008) Matthew N. Hill et al. JOURNAL OF NEUROCHEMISTRY
- A 14-week, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trial of Pregabalin in Patients With Fibromyalgia
- (2008) Lesley M. Arnold et al. JOURNAL OF PAIN
- Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
- (2008) Vincenzo Micale et al. NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More